A gene encoding a family with sequence similarity 84, member a (FAM84A) enhanced migration of human colon cancer cells

International Journal of Oncology

Volumn 29, Issue 2, 2006, Pages 341-347

  Kobayashi, Takaaki ^a,b   Masaki, Tadahiko ^b   Sugiyama, Masanori ^b   Atomi, Yutaka ^b   Furukawa, Yoichi ^a   Nakamura, Yusuke ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYORIN UNIVERSITY   (Japan)

Author keywords

Colon cancer; FAM84A; Migration

Indexed keywords

COMPLEMENTARY DNA; FAM84A PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL MOTION; CELL STRAIN 3T3; COLON TUMOR; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; TISSUE DISTRIBUTION; UPREGULATION;

ANIMALS; CELL MOVEMENT; COLONIC NEOPLASMS; DISEASE PROGRESSION; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASM PROTEINS; NIH 3T3 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 39049184076     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.2.341     Document Type: Article

References (19)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ and Thun MJ: American Cancer Society: Cancer stastistics, 2004. CA Cancer J Clin 54: 8-29, 2004.
2. Tamakoshi K, Wakai K, Kojima M, Watanabe Y, Hayakawa N, Toyoshima H, Yatsuya H, Kondo T, Tokudome S, Hashimoto S, Suzuki K, Ito Y and Tamakoshi A: JACC Study Group: a prospective study of body size and colon cancer mortality in Japan. The JACC Study. Int J Obes Relat Metab Disord 28: 551-558, 2004.
3. Sakamoto J, Ohashi Y, Hamada C, Buyse M, Burzykowski T and Piedbois P: Meta-Analysis Group of the Japanese Society for Cancer of the Colon and Rectum; Meta-Analysis Group in Cancer: efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials. J Clin Oncol 22: 484-492, 2004.
4. Weitz J, Koch M, Debus J, Hohler T, Galle PR and Buchler MW: Colorectal cancer. Lancet 365: 153-165, 2005.
5. Heijstek MW, Kranenburg O and Borel Rinkes IH: Mouse models of colorectal cancer and liver metastases. Dig Surg 22: 16-25, 2005. (Pubitemid 40754685)
6. Saha D, Roman C and Beauchamp RD: New strategies for colorectal cancer prevention and treatment. World J Surg 26: 762-766, 2002. (Pubitemid 36920314)
7. De la Chapelle A: Genetic predisposition to colorectal cancer. Nat Rev Cancer 4: 769-780, 2004.
8. Feinberg AP and Tycko B: The history of cancer epigenetics. Nat Rev Cancer 4: 143-153, 2004.
9. Robertson KD: DNA methylation and human disease. Nat Rev Genet 6: 597-610, 2005.
10. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR and Feinberg AP: Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299: 1753-1755, 2003. (Pubitemid 36337205)
11. Geho DH, Bandle RW, Clair T and Liotta LA: Physiological mechanisms of tumor-cell invasion and migration. Physiology 20: 194-200, 2005. (Pubitemid 40807057)
12. Lin YM, Furukawa Y, Tsunoda T, Yue CT, Yang KC and Nakamura Y: Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 21: 4120-4128, 2002. (Pubitemid 34712879)
13. Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL and Kleinman HK: Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J 11: 472-481, 1997.
14. Guo W and Giancotti FG: Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5: 816-826, 2004.
15. Izard T, Evans G, Borgon RA, Rush CL, Bricogne G and Bois P: Vincullin activation by talin though helical bundle conversion. Nature 427: 171-175, 2004. (Pubitemid 38094959)
16. Adam PJ, Boyd R, Tyson KL, Fletcher GC, Stamps A, Hudson L, Poyser HR, Redpath N, Griffiths M, Steers G, Harris AL, Patel S, Berry J, Loader JA, Townsend RR, Daviet L, Legrain P, Parekh R and Terrett JA: Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J Biol Chem 278: 6482-6489, 2003.
17. Bjorklund M and Koivunen E: Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755: 37-69, 2005. (Pubitemid 40720240)
18. Hakem A, Sanchez-Sweatman O, You-Ten A, Duncan G, Wakeham A, Khokha R and Mak TW: RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev 19: 1974-1979, 2005.
19. Wheeler AP and Ridley AJ: Why three Rho proteins? RhoA, RhoB, RhoC and cell motility. Exp Cell Res 301: 43-49, 2004.